{
  "segment": [
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品",
      "sales": 66340,
      "profit": 8255,
      "assets": 74380
    },
    {
      "FY": "FY14",
      "period": "2015/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能食品",
      "sales": 13651,
      "profit": 307,
      "assets": 10777
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品",
      "sales": 70489,
      "profit": 8389,
      "assets": 76037
    },
    {
      "FY": "FY15",
      "period": "2016/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能食品",
      "sales": 13720,
      "profit": 159,
      "assets": 10167
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "医薬品",
      "sales": 85315,
      "profit": 14690,
      "assets": 79208
    },
    {
      "FY": "FY16",
      "period": "2017/3",
      "unit": "百万円",
      "accounting_standard": "JGAAP",
      "consolidation": "連結",
      "segment": "機能食品",
      "sales": 13466,
      "profit": 589,
      "assets": 10155
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "医薬品",
      "sales": 87416,
      "profit": 16351,
      "assets": 88285
    },
    {
      "FY": "FY17",
      "period": "2018/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "機能食品",
      "sales": 14031,
      "profit": 728,
      "assets": 10914
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "医薬品",
      "sales": 100223,
      "profit": 19679,
      "assets": 93772
    },
    {
      "FY": "FY18",
      "period": "2019/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "機能食品",
      "sales": 14492,
      "profit": 965,
      "assets": 10879
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "医薬品",
      "sales": 101643,
      "profit": 20686,
      "assets": 98623
    },
    {
      "FY": "FY19",
      "period": "2020/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "機能食品",
      "sales": 14994,
      "profit": 982,
      "assets": 11218
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "医薬品",
      "sales": 106478,
      "profit": 25949,
      "assets": 112408
    },
    {
      "FY": "FY20",
      "period": "2021/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "機能食品",
      "sales": 15380,
      "profit": 774,
      "assets": 11122
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "医薬品",
      "sales": 120650,
      "profit": 32244,
      "assets": 121515
    },
    {
      "FY": "FY21",
      "period": "2022/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "機能食品",
      "sales": 16834,
      "profit": 529,
      "assets": 13431
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "医薬品",
      "sales": 121988,
      "profit": 28771,
      "assets": 127207
    },
    {
      "FY": "FY22",
      "period": "2023/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "機能食品",
      "sales": 22187,
      "profit": 574,
      "assets": 16114
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "医薬品",
      "sales": 125105,
      "profit": 30638,
      "assets": 151253
    },
    {
      "FY": "FY23",
      "period": "2024/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "機能食品",
      "sales": 23150,
      "profit": 1393,
      "assets": 14414
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "医薬品",
      "sales": 138654,
      "profit": 33542,
      "assets": 175655
    },
    {
      "FY": "FY24",
      "period": "2025/3",
      "unit": "百万円",
      "accounting_standard": "IFRS",
      "consolidation": "連結",
      "segment": "機能食品",
      "sales": 21577,
      "profit": 1269,
      "assets": 14148
    }
  ]
}